A promising step forward in prostate cancer treatment

When treating prostate cancer with radiotherapy, knowing the prostate cancer position is critical to accurately targeting the radiation beam to avoid missing the tumour and irradiating healthy tissue. Prostate cancer patients being treated with radiotherapy can now have their prostate position known to within 0.5mm during radiation treatment thanks to a study led by Professor Paul Keall, NHMRC Australia Fellow at the University of Sydney.

In a world-first the new tracking system has been implemented in a 10-patient at the Royal North Shore Hospital. The technique termed 'KIM' for Kilovoltage Intrafraction Monitoring uses X-rays during the to measure the position of markers implanted into the prostate though a novel two-dimension-to-three dimension calculation method.

The system was originally conceived at Stanford University in 2008 by two of the investigators of this research, Professor Keall and Associate Professor Per Poulsen, and is a collaboration between the University of Sydney, Royal North Shore Hospital and Aarhus University in Denmark. In the current study, prostate cancer motion of over 10mm was seen during treatment.

The overall accuracy of the system was higher than 0.5mm, better than other dedicated commercial prostate monitoring systems that can be purchased but have not been widely implemented in clinical practice. As well as being more accurate, an additional advantage of the KIM system over the dedicated systems is that it uses readily available radiation therapy equipment, so there is enormous potential for low cost routine use of the system worldwide.

"KIM is exciting for patients because it's going to open up a new area of , real-time tumour tracking," said Dr Thomas Eade, a at the Royal North Shore Hospital. "But, it could potentially be available to all patients that are treated using standard machines."

Using the KIM system X-rays to measure the prostate motion adds a small amount of additional imaging dose delivered to the patient - approximately one percent of the treatment dose in the current studies, though there is potential for improvement. "KIM was implemented within the constraints of an existing clinical cancer radiotherapy system," said Professor Paul Keall. "We have several ideas to explore to make the system even more accurate with lower imaging dose."

In the future, the research team plan to use the KIM information to pause and adjust the treatment when the prostate cancer position moves beyond the target of the . Ultimately, they plan to continuously align the radiation beam with the cancer throughout the treatment.

More information: A paper based on this work has been accepted for publication in the International Journal of Radiation Oncology, Biology, Physics.

add to favorites email to friend print save as pdf

Related Stories

Radiation therapy combo cures prostate cancer long-term

Jan 04, 2007

Seventy-four percent of men treated with a combination of radiation seed implants and external beam radiation therapy for prostate cancer are cured of their disease 15 years following their treatment, according to a study ...

Recommended for you

Pepper and halt: Spicy chemical may inhibit gut tumors

10 hours ago

Researchers at the University of California, San Diego School of Medicine report that dietary capsaicin – the active ingredient in chili peppers – produces chronic activation of a receptor on cells lining ...

Expressive writing may help breast cancer survivors

11 hours ago

Writing down fears, emotions and the benefits of a cancer diagnosis may improve health outcomes for Asian-American breast cancer survivors, according to a study conducted by a researcher at the University of Houston (UH).

Taking the guesswork out of cancer therapy

17 hours ago

Researchers and doctors at the Institute of Bioengineering and Nanotechnology (IBN), Singapore General Hospital (SGH) and National Cancer Centre Singapore (NCCS) have co-developed the first molecular test ...

Brain tumour cells found circulating in blood

18 hours ago

(Medical Xpress)—German scientists have discovered rogue brain tumour cells in patient blood samples, challenging the idea that this type of cancer doesn't generally spread beyond the brain.

International charge on new radiation treatment for cancer

19 hours ago

(Medical Xpress)—Imagine a targeted radiation therapy for cancer that could pinpoint and blast away tumors more effectively than traditional methods, with fewer side effects and less damage to surrounding tissues and organs.

User comments